MGRX News
Archived Headlines
- Men's wellness products provider Mangoceuticals postpones $5 million IPO 02/15/23
- Men's wellness products provider Mangoceuticals sets proposed price at $4 ahead of $5 million IPO 01/26/23
- US IPO Weekly Recap: Skyward completes $134 million offering while several large issuers enter the pipeline 01/13/23
- Men's wellness products provider Mangoceuticals files and sets terms for a $5 million IPO 01/13/23
US IPO Weekly Recap: Small deals slip through the IPO window
Four small issuers began trading this past week, three of which are eligible for inclusion in our IPO stats, joined by one SPAC. In the pipeline, two small IPOs and one direct listing submitted initial filings. The most notable activity came from car sharing...read more
Men's wellness products provider Mangoceuticals prices IPO at $4
Mangoceuticals, which provides an erectile dysfunction product via telehealth, raised $5 million by offering 1.3 million shares at $4, as expected. Mangoceuticals plans to connect consumers to licensed healthcare professionals through its recently launched...read more
US IPO Week Ahead: IPO calendar marches on with more small deals
Three small IPOs are currently on the calendar for the week ahead. Chinese grain producer YanGuFang International Group (YGF) may price in the week ahead, planning to raise $13 million at a $163 million market cap. The company’s...read more
US IPO Weekly Recap: Calendar is quieter than expected as more small IPOs join the pipeline
Two small issuers began trading this past week, only one of which was large enough to be included in our IPO stats, as several deals postponed (SODR, MGRX) or delayed (TRNR, INTS, NRXS). Two SPACs also priced. Eight IPOs submitted initial filings, the...read more